Pulmonary Function Testing Systems Market Size & Growth Forecast 2027–2036, By Segments (Application, End Use, Test Type, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Pulmonary Function Testing Systems Market size was estimated at USD 3.1 Billion in 2026 and is projected to grow at 7.31% CAGR from 2027 to 2036, reaching USD 6.28 Billion by 2036. The industry revenue for 2027 is assessed at USD 3.29 Billion.
Get more details on this report
Request Free Sample ReportPulmonary Function Testing Systems Market Intelligence Snapshot
Regional Market Dynamics
- North America led in 2026, supported by advanced healthcare infrastructure, respiratory care practices, established reimbursement, and demand for accurate diagnostics and continuous disease monitoring.
- Asia Pacific is growing fastest as healthcare infrastructure, diagnostic access, respiratory disease awareness, healthcare spending, and digital testing adoption expand across emerging healthcare markets.
Segment Momentum
- Spirometry led the market in 2026 because it is widely available, non-invasive, cost-effective, and delivers rapid clinical results, making it the standard test for diagnosing and monitoring a broad range of respiratory conditions.
- Homecare settings are expanding rapidly due to growing demand for patient-centered care, portable pulmonary monitoring devices, remote patient monitoring, and telehealth integration for managing chronic respiratory diseases outside traditional healthcare facilities.
Market Expansion Drivers
- Rising prevalence of chronic respiratory diseases increasing demand for diagnostic testing systems
- Government health initiatives supporting early diagnosis and respiratory disease screening programs
- Advancements in portable pulmonary testing devices enabling decentralized respiratory diagnostics
Leading Market Participants
- Major players in the pulmonary function testing systems market include Baxter International Inc. (United States), Philips N.V. (Netherlands), COSMED Srl (Italy), Schiller AG (Switzerland), Vyaire Medical Inc. (United States), MGC Diagnostics Corporation (United States), ndd Medizintechnik AG (Switzerland), Vitalograph Ltd. (Ireland), Fukuda Sangyo Co., Ltd. (Japan), Minato Medical Science Co., Ltd. (Japan)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 3.1 Billion
- 2027 Estimated Market Size: USD 3.29 Billion
- Projected Market Size: USD 6.28 Billion by 2036
- Growth Forecast: 7.31% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Chronic Obstructive Pulmonary Disease (Application) | Hospitals & Clinics (End Use) | Spirometry (Test Type) | Handheld (Product)
- Emerging Opportunity Segment: Asthma (Application) | Homecare Settings (End Use) | Gas Diffusion Test (Test Type) | Handheld (Product)
Market Growth Drivers and Industry Trends
Rising prevalence of chronic respiratory diseases increasing demand for diagnostic testing systems
The increasing burden of respiratory conditions is creating greater demand for accurate lung assessment and monitoring technologies, which will drive the pulmonary function testing systems market growth. Healthcare providers are relying on pulmonary testing systems to evaluate respiratory performance, support disease diagnosis, and monitor treatment effectiveness. As respiratory health management becomes a larger focus across healthcare settings, diagnostic solutions that enable detailed lung function analysis are gaining importance.
Government health initiatives supporting early diagnosis and respiratory disease screening programs
Public health programs focused on improving respiratory disease detection are encouraging broader implementation of testing procedures, strengthening adoption across the pulmonary function testing systems market. Early screening initiatives help healthcare professionals identify respiratory abnormalities sooner and improve disease management outcomes. Increased attention toward preventive healthcare and population-level respiratory monitoring is supporting the integration of pulmonary testing technologies in clinical environments.
Advancements in portable pulmonary testing devices enabling decentralized respiratory diagnostics
Technological improvements in compact and portable testing equipment are expanding access to respiratory diagnostics beyond traditional hospital settings, boosting growth within the pulmonary function testing systems market. Portable devices allow healthcare providers to perform lung assessments in outpatient facilities, community healthcare centers, and remote locations. These innovations are improving diagnostic accessibility while supporting more flexible respiratory care delivery models.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of chronic respiratory diseases increasing demand for diagnostic testing systems | 2% | High | North America, Europe | High | Near Term |
| Government health initiatives supporting early diagnosis and respiratory disease screening programs | 1.7% | High | Asia Pacific, Europe | High | Mid Term |
| Advancements in portable pulmonary testing devices enabling decentralized respiratory diagnostics | 1.5% | Moderate | North America, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest position in the pulmonary function testing systems market in 2026, supported by advanced healthcare infrastructure, established respiratory care practices, and strong demand for diagnostic technologies. The region has a high burden of respiratory conditions, including chronic pulmonary disorders, which sustains the need for accurate assessment of lung function across hospitals, specialty clinics, and diagnostic facilities. Increasing emphasis on early detection and continuous monitoring is encouraging healthcare providers to adopt sophisticated testing systems with improved accuracy and digital capabilities. In addition, established reimbursement structures, clinical awareness, and ongoing investments in healthcare technology are supporting the integration of pulmonary function testing into routine respiratory disease management.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to be the fastest-growing region in the pulmonary function testing systems market, driven by expanding healthcare infrastructure, rising awareness of respiratory diseases, and improving access to diagnostic services. Growing urbanization and exposure to environmental pollution are increasing attention toward respiratory health, while expanding healthcare expenditure is enabling hospitals and diagnostic centers to introduce advanced testing equipment. The development of specialized respiratory care facilities and increasing adoption of digital diagnostic technologies are also creating favorable conditions for market expansion. As healthcare systems across emerging economies strengthen their diagnostic capabilities, demand for accessible and reliable pulmonary testing is likely to broaden across both urban and developing healthcare markets.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Integrated Respiratory DiagnosticsThe U.S. market is emphasizing pulmonary function testing systems that integrate with hospital information systems and outpatient respiratory care networks. Rising attention to chronic respiratory disease management is encouraging investment in connected diagnostic platforms and portable testing capabilities.
Germany 🇩🇪
Precision Testing StandardsGermany prioritizes pulmonary function testing systems that deliver standardized measurements and support specialized respiratory clinics. Healthcare providers are upgrading equipment to improve diagnostic consistency and expand testing capacity for chronic pulmonary conditions.
Japan 🇯🇵
Aging Care AssessmentJapan is expanding the use of pulmonary function testing systems to support respiratory monitoring among its aging population. Hospitals and community healthcare providers are adopting compact and easy-to-operate systems suited to routine lung function assessments.
South Korea 🇰🇷
Digitally Connected DiagnosticsSouth Korea is advancing pulmonary function testing systems that connect with electronic medical records and telehealth infrastructure. Providers are seeking solutions that streamline respiratory assessments and improve clinical workflow efficiency across healthcare facilities.
France 🇫🇷
Preventive Respiratory ScreeningFrance is strengthening the use of pulmonary function testing systems within preventive respiratory care and specialist referral pathways. Demand is increasing for equipment that supports early diagnosis and regular monitoring of chronic respiratory disorders.
Italy 🇮🇹
Hospital Modernization ProgramsItaly is modernizing pulmonary diagnostics through equipment upgrades in hospitals and respiratory centers. The market is focusing on systems that improve testing accuracy and provide broader access to lung function evaluation across regional healthcare networks.
Segment Leadership and Growth Trends
Pulmonary Function Testing Systems Market Share (%), by Application, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportApplication Segment Analysis: Chronic Obstructive Pulmonary Disease (Largest Segment) vs Asthma (Fastest-Growing Segment)
The chronic obstructive pulmonary disease application segment led the pulmonary function testing systems market, capturing 42.98% in 2026. The high prevalence of chronic respiratory disorders, the need for continuous assessment of lung function, and the importance of early diagnosis and disease progression monitoring contributed to its dominant position. Pulmonary function testing plays a vital role in treatment planning, evaluating therapeutic effectiveness, and supporting long-term patient management, reinforcing demand across healthcare settings.
The asthma application segment is anticipated to register the fastest growth as awareness of respiratory health continues to improve and diagnosis rates increase across both pediatric and adult populations. Expanding screening initiatives, greater emphasis on preventive care, and the growing use of lung function assessments for routine monitoring are supporting wider adoption of pulmonary function testing among individuals with asthma.
Test Type Segment Analysis: Spirometry (Largest Segment) vs Gas Diffusion Test (Fastest-Growing Segment)
The spirometry segment held the largest share in 2026. Spirometry remains the primary diagnostic test for evaluating lung function because it is widely available, non-invasive, cost-effective, and capable of delivering rapid clinical results. Its routine use in diagnosing and monitoring a broad range of respiratory conditions has established it as the standard pulmonary function assessment across hospitals, clinics, and diagnostic facilities.
Holding the strongest growth outlook, the gas diffusion test segment is gaining momentum in the pulmonary function testing systems market due to its increasing use in assessing disorders that affect gas exchange within the lungs. Rising clinical attention toward interstitial lung diseases and other complex pulmonary conditions, along with advances in diagnostic capabilities, is expanding the adoption of gas diffusion testing in specialized respiratory care.
End Use Segment Analysis: Hospitals & Clinics (Largest Segment) vs Homecare Settings (Fastest-Growing Segment)
Hospitals and clinics represented the largest end-use segment in 2026. Their leadership is supported by the availability of specialized respiratory care services, advanced diagnostic equipment, and trained healthcare professionals capable of performing comprehensive pulmonary assessments. These facilities also manage a high volume of patients requiring diagnosis, treatment planning, and ongoing monitoring for chronic respiratory diseases.
The homecare settings segment is expected to experience the fastest growth. Increasing preference for patient-centered care, expanding availability of portable pulmonary monitoring devices, and the growing focus on managing chronic respiratory diseases outside traditional healthcare facilities are encouraging wider adoption. Remote patient monitoring and telehealth integration are also strengthening the role of home-based pulmonary function testing.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Application | Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath, Pulmonary Fibrosis, Others | Chronic Obstructive Pulmonary Disease | Asthma |
| End Use | Hospitals & Clinics, Diagnostic Centers, Homecare Settings, Others | Hospitals & Clinics | Homecare Settings |
| Test Type | Spirometry, Exercise Stress Test, Lung Volume Test, High Altitude Simulation Testing, Gas Diffusion Test, Others | Spirometry | Gas Diffusion Test |
| Product | Handheld, Tabletop | Handheld | Handheld |
Competitive Landscape and Market Positioning
Key companies in the pulmonary function testing systems market:
- Baxter International, Inc. (United States)
- Philips N.V. (Netherlands)
- COSMED Srl (Italy)
- Schiller AG (Switzerland)
- Vyaire Medical, Inc. (United States)
- MGC Diagnostics Corporation (United States)
- ndd Medizintechnik AG (Switzerland)
- Vitalograph Ltd. (Ireland)
- FUKuda Sangyo Co., Ltd. (Japan)
- Minato Medical Science Co., Ltd. (Japan)
Clinical demand for faster and more consistent respiratory assessment is encouraging suppliers to refine pulmonary function testing systems through improved diagnostic accuracy, workflow integration, and digital data management rather than hardware enhancements alone. Vendors are expanding software capabilities that support standardized reporting, electronic health record compatibility, and remote review of patient data, allowing healthcare providers to streamline respiratory care across multiple clinical settings. Competition is also evolving around ease of use, calibration efficiency, and flexible deployment options that enable reliable testing in hospitals, specialty clinics, and decentralized care environments.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Baxter International Inc. (United States) | |||||||
| Philips N.V. (Netherlands) | |||||||
| COSMED Srl (Italy) | |||||||
| Schiller AG (Switzerland) | |||||||
| Vyaire Medical Inc. (United States) | |||||||
| MGC Diagnostics Corporation (United States) | |||||||
| ndd Medizintechnik AG (Switzerland) | |||||||
| Vitalograph Ltd. (Ireland) | |||||||
| Fukuda Sangyo Co. Ltd. (Japan) | |||||||
| Minato Medical Science Co. Ltd. (Japan) |
Industry Development/News
| Company Name | Date | Key Development |
|---|
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Pulmonary Function Testing Systems Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Patient Age Group | Pediatric, Adult, Geriatric |
| Automation Level | Manual, Semi-Automated, Fully Automated |
| Purchase Model | Direct Purchase, Distributor Purchase, Managed Equipment Services |
Pulmonary Function Testing Systems Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Pulmonary Diagnostics Infrastructure Assessment |
|
| Diagnostic Care Pathway Integration Analysis |
|
| Digital Pulmonary Monitoring Ecosystem |
|
Need a different cut of the data?
Request Custom ResearchHow large is the pulmonary function testing systems market?
How is the pulmonary function testing systems industry expected to grow over the next 10 years?
How are advances in portable testing systems transforming the pulmonary function testing systems market?
Why are early respiratory screening initiatives driving adoption of pulmonary function testing systems?
Why is spirometry the leading test type in the pulmonary function testing systems market?
Why are homecare settings the fastest-growing end-use segment?
What supports North America’s leadership in pulmonary function testing systems?
How is Asia Pacific driving faster growth in pulmonary function testing systems?
Who holds a significant market share in the pulmonary function testing systems landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization